10/6/2026
FDA seeks public input on ibogaine trial design
Request focuses on safety, dosing, and oversight for early-phase trials.
Topic archive
psychedelic medicine
7 stories
9/24/2026
NeuroThera and Clearmind expand U.S. patent portfolio
Collaboration focuses on LSD, ketamine, and ibogaine combinations.
9/8/2026
Ibogaine and the bicameral mind book release highlights growing interest
Jonathan Dickinson's new book explores ibogaine's therapeutic potential amid rising U.S. policy focus.
8/27/2026
Psychedelic medicine gains momentum globally
Israel urged to engage in psychedelic research and development.
8/6/2026
Barrow Neurological Institute secures $5M for ibogaine TBI trial
The trial will explore ibogaine's potential to treat traumatic brain injury, starting in 2027.
8/6/2026
Barrow Institute gets $5M for ibogaine brain injury trial
The trial will explore ibogaine's potential in treating chronic TBI symptoms.
8/6/2026
Barrow begins ibogaine trial for brain injury recovery
Arizona-funded study explores ibogaine's potential for neurological disorders.